While these differences may occur because we studied different ACTG2 mutations, primary human bowel smooth muscle might alternatively possess specialized regulatory mechanisms absent from U2OS sarcoma that maintain normal total F-actin levels when ACTG2R257C is present and that influence ACTG2 localization in filaments. Here, ACTG2 is linked to sarcoma.